Seongnam-si, South Korea

Jong-su Yoo

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jong-su Yoo: Innovator in Medical Technology

Introduction

Jong-su Yoo is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of medical technology, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and stability of medications through advanced delivery methods.

Latest Patents

One of Jong-su Yoo's most significant inventions is a patent for a rivastigmine patch designed for long-term administration. This patch comprises a high content of rivastigmine per unit area, allowing for continuous administration over an extended period. The rivastigmine patch is capable of releasing the drug for a duration of at least three days, with the potential for four days or more after attachment. This invention demonstrates excellent physical and chemical stability, making it a valuable advancement in patient care.

Career Highlights

Jong-su Yoo is currently associated with SK Chemicals Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has garnered attention for its potential to improve the quality of life for patients requiring long-term medication management.

Collaborations

Jong-su Yoo has collaborated with talented colleagues, including Namho Kim and Wonjae Choi, to further enhance the development of medical technologies. Their combined expertise contributes to the success of their projects and the advancement of healthcare solutions.

Conclusion

Jong-su Yoo's contributions to medical technology, particularly through his rivastigmine patch, highlight his commitment to improving patient care. His innovative approach and collaboration with skilled professionals position him as a key figure in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…